(19)
(11) EP 1 227 846 A2

(12)

(88) Date of publication A3:
06.12.2001

(43) Date of publication:
07.08.2002 Bulletin 2002/32

(21) Application number: 00975626.3

(22) Date of filing: 10.11.2000
(51) International Patent Classification (IPC)7A61K 45/00
(86) International application number:
PCT/US0030/924
(87) International publication number:
WO 0134/201 (17.05.2001 Gazette 2001/20)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 12.11.1999 US 165218 P

(71) Applicants:
  • ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, Inc.
    Indianapolis, IN 46202 (US)
  • Clapp, Wade D.
    Indianapolis, IN 46278 (US)
  • Ingram, David A.
    Indianapolis, IN 46220 (US)
  • Marshall, Mark Steven
    Carmel, IN 46033 (US)

(72) Inventors:
  • CLAPP, Wade, D.
    Indianapolis, IN 46278 (US)
  • INGRAM, David, A.
    Indianapolis, IN 46220 (US)
  • MARSHALL, Mark, Steven
    Carmel, IN 46033 (US)

(74) Representative: Wiklund, Erik et al
AWAPATENT AB,Box 5117
200 71 Malmö
200 71 Malmö (SE)

   


(54) METHODS FOR INHIBITING NEUROFIBROMATOSIS TYPE 1 (NF1)